The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
Open accessAbstract
PurposeDespite their controversial role, corticosteroids (CS) are frequently administered to patients with H1N1 virus infection with severe respiratory failure secondary to viral pneumonia. We hypothesized that invasive pulmonary aspergillosis (IPA) is a frequent complication in critically ill patients with H1N1 virus infection and that CS may contribute to this complication.MethodsWe retrospectively selected all adult patients with confirmed H1N1 virus infection admitted to the intensive care unit (ICU) of two tertiary care hospitals from September 2009 to March 2011. Differences in baseline factors, risk factors, and outcome parameters were studied between patients with and without IPA.ResultsOf 40 critically ill patients with confirmed H1N1, 9 (23 %) developed IPA 3 days after ICU admission. Five patients had proven and four had probable IPA. Significantly more IPA patients received CS within 7 days before ICU admission (78 versus 23 %, p = 0.002). IPA patients also received significantly higher doses of CS before ICU admission [hydrocortisone equivalent 800 (360–2,635) versus 0 (0–0) mg, p = 0.005]. On multivariate analysis, use of CS before ICU admission was independently associated with IPA [odds ratio (OR) 14.4 (2.0–101.6), p = 0.007].ConclusionsIPA was diagnosed in 23 % of critically ill patients with H1N1 virus infection after a median of 3 days after ICU admission. Our data suggest that use of CS 7 days before ICU admission is an independent risk factor for fungal superinfection. These findings may have consequences for clinical practice as they point out the need for increased awareness of IPA, especially in those critically ill H1N1 patients already receiving CS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917
Sehulster, L. M., & Chinn, R. Y. W. (2003) · PubMed · Cited by 1,708
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Kumar, A. (2009) · JAMA · doi:10.1001/jama.2009.1496 · Cited by 1,425
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
(2010) · New England Journal of Medicine · doi:10.1056/nejmra1000449 · Cited by 1,062
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908481 · Cited by 1,001
Critically Ill patients with 2009 influenza A(H1N1) in Mexico
Domínguez-Cherit, G. (2009) · JAMA · doi:10.1001/jama.2009.1536 · Cited by 840
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Invasive aspergillosis in critically ill patients without malignancy
Meersseman, W., Vandecasteele, S. J., Wilmer, A., Verbeken, E., Peetermans, W. E., & Van Wijngaerden, E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-093oc · Cited by 547
Self-citationLung Pathology in Fatal Novel Human Influenza A (H1N1) Infection
Mauad, T., Hajjar, L. A., Callegari, G. D., da Silva, L. F. F., Schout, D., Galas, F. R. B. G., Alves, V. A. F., Malheiros, D. M. A. C., Auler, J. O. C., Ferreira, A. F., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1420oc · Cited by 547 · cited 1×
“A recent study of lung pathology in fatal H1N1 cases suggested that viral overload leads to altered immune responses, as with fatal H5N1 cases [32].”
BackgroundGalactomannan in Bronchoalveolar Lavage Fluid
Meersseman, W., Lagrou, K., Maertens, J., Wilmer, A., Hermans, G., Vanderschueren, S., Spriet, I., Verbeken, E., & Van Wijngaerden, E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-606oc · Cited by 496
Self-citationGuinea, J., Torres-Narbona, M., Gijón, P., Muñoz, P., Pozo, F., Peláez, T., de Miguel, J., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03015.x · Cited by 397
Invasive aspergillosis in the intensive care unit
Meersseman, W., Lagrou, K., Maertens, J., & Wijngaerden, E. V. (2007) · Clinical Infectious Diseases · doi:10.1086/518852 · Cited by 366
Self-citationPeter, J. V., John, P., Graham, P. L., Moran, J. L., George, I. A., & Bersten, A. (2008) · BMJ · doi:10.1136/bmj.39537.939039.be · Cited by 357
Tang, B. M. P., Craig, J. C., Eslick, G. D., Seppelt, I., & McLean, A. S. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819fb507 · Cited by 351
Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome
Brun-Buisson, C., Richard, J.-C. M., Mercat, A., Thiébaut, A. C. M., & Brochard, L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0135oc · Cited by 338
Stynen, D., Goris, A., Sarfati, J., & Latgé, J. P. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.2.497-500.1995 · Cited by 330
Vandewoude, K. H., Blot, S. I., Depuydt, P., Benoit, D., Temmerman, W., Colardyn, F., & Vogelaers, D. (2006) · Critical Care · doi:10.1186/cc4823 · Cited by 268
Garnacho-Montero, J., Amaya-Villar, R., Ortiz-Leyba, C., León, C., Álvarez-Lerma, F., Nolla-Salas, J., Iruretagoyena, J. R., & Barcenilla, F. (2005) · Critical Care · doi:10.1186/cc3488 · Cited by 252
Kim, S.-H., Hong, S.-B., Yun, S.-C., Choi, W.-I., Ahn, J.-J., Lee, Y. J., Lee, H.-B., Lim, C.-M., & Koh, Y. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0110oc · Cited by 218
Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis
Ng, T. T. C., Robson, G. D., & Denning, D. W. (1994) · Microbiology · doi:10.1099/13500872-140-9-2475 · Cited by 217
Martin-Loeches, I., Lisboa, T., Rhodes, A., Moreno, R. P., Silva, E., Sprung, C., Chiche, J. D., Barahona, D., Villabon, M., Balasini, C., et al. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2078-z · Cited by 210
Bulpa, P. A., Dive, A., Garrino, M.-G., Delos, M., Gonzalez, M. R., Evrard, P., Glupczynski, Y., & Installé, E. (2000) · Intensive Care Medicine · doi:10.1007/s001340000768 · Cited by 129
Vandewoude, K., Blot, S. I., Benoît, D., Colardyn, F., & Vogelaers, D. (2004) · Journal of Hospital Infection · doi:10.1016/j.jhin.2004.01.006 · Cited by 124
Xi, X., Xu, Y., Jiang, L., Li, A., Duan, J., & Du, B. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-256 · Cited by 112
García‐Vidal, C., Barba, P., Arnán, M., Moreno, A., Ruíz-Camps, I., Gudiol, C., Ayats, J., Ortí, G., & Carratalà, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir485 · Cited by 108
Invasive Aspergillosis after Pandemic (H1N1) 2009
Lat, A., Bhadelia, N., Miko, B. A., Furuya, E. Y., & Thompson, G. R. (2010) · Emerging infectious diseases · doi:10.3201/eid1606.100165 · Cited by 96
Acute Community-Acquired Pneumonia due to Aspergillus in Presumably Immunocompetent Hosts
Clancy, C. J., & Nguyen, M. H. (1998) · CHEST Journal · doi:10.1378/chest.114.2.629 · Cited by 94
Giannella, M., Alonso, M., de Viedma, D. G., López-Roa, P., Catalán, P., Padilla, B., Muñóz, P., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03399.x · Cited by 91
Pulmonary Aspergillosis Following Post-influenzal Bronchopneumonia Treated with Antibiotics
Abbott, J., Fernando, H. V. J., Gurling, K. J., & Meade, B. W. (1952) · BMJ · doi:10.1136/bmj.1.4757.523 · Cited by 90
H1N1: viral pneumonia as a cause of acute respiratory distress syndrome
Ramsey, C. D., & Kumar, A. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283427259 · Cited by 70
Influenza virus infection induces functional alterations in peripheral blood lymphocytes.
Lewis, D. E., Gilbert, B. E., & Knight, V. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.12.3777 · Cited by 69
Clinical analysis of deep cutaneous mycoses: a 12‐year experience at a single institution
Kim, M., Lee, S., Sung, H. S., Won, C. H., Chang, S. E., Lee, M. W., Choi, J. ‐., & Moon, K. C. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02191.x · Cited by 40
Vehreschild, J. J., Bröckelmann, P. J., Bangard, C., Verheyen, J., Vehreschild, M. J. G. T., Michels, G., Wisplinghoff, H., & Cornely, O. A. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811002603 · Cited by 32
Isolation of Aspergillus in three 2009 H1N1 influenza patients
Adalja, A. A., Sappington, P. L., Harris, S. P., Rimmele, T. R., Kreit, J. W., Kellum, J. A., & Boujoukos, A. J. (2011) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2011.00202.x · Cited by 28
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis
Kim, S., Kim, M., Lee, S., Choi, S., Kim, Y. S., Woo, J. H., Lim, C., Koh, Y., & Hong, S. (2011) · Mycoses · doi:10.1111/j.1439-0507.2011.02051.x · Cited by 17
Passouant, O., Mateu, P., Commandini, M., Brenkle, K., & Just, B. (2011) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2011.07.010 · Cited by 11
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Schauwvlieghe, A. F. A. D., Rijnders, B. J. A., Philips, N., Verwijs, R., Vanderbeke, L., Van Tienen, C., Lagrou, K., Verweij, P. E., Van de Veerdonk, F. L., Gommers, D., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30274-1 · Cited by 886
Self-citationThe clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Verweij, P. E., Rijnders, B. J. A., Brüggemann, R. J. M., Azoulay, E., Bassetti, M., Blot, S., Calandra, T., Clancy, C. J., Cornely, O. A., Chiller, T., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06091-6 · Cited by 459
Self-citation
Metadata
- Authors
- Wauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., Lagrou, K., Wilmer, A., Jorens, P., & Hermans, G.
- Venue
- Intensive Care Medicine
- Published
- 2012-08-16
- Volume
- 38
- Issue
- 11
- Pages
- 1761-1768
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2026230041
- Cited by
- 265
- References
- 36
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.